2017 Life Sciences Dealmaking Symposium
M&A Outlook: 2017 Trends and Predictions for 2018
We are pleased to announce that Gabriele Brambilla, CEO of Alira Health, was selected as a panelist for the M&A Outlook panel at McDermott Will & Emery’s 2017 Life Sciences Dealmaking Symposium.
Alira Health knows how to leverage mergers and acquisitions to grow healthcare and life science companies. We provide a more strategic M&A approach based on our in-depth knowledge of the commercial drivers, market players, and growth trends in your space. We work with you to identify and select appropriate investors and investments so you can close on the opportunities most likely to deliver long-term profitability and value.
Our M&A advisors are also scientists, doctors and MBAs who fully understand the complexities of corporate finance requirements. They have a successful track-record of helping healthcare and life science companies of all sizes through the challenges and opportunities of M&A transactions.
Attend The 2017 Life Sciences Dealmaking Symposium and meet with Alira Health experts! Please contact firstname.lastname@example.org to schedule your meeting or request more information. We look forward to helping you with your healthcare and life science needs.
October 04, 2017
Royal Sonesta Boston
40 Edwin H Land Boulevard
Cambridge, MA 02142